New ACRF Target Drug Discovery Platform

Friday 3 February 2017

The Target and Drug Discovery Platform (TDDP), located within the Biomolecular Resource Facility at the John Curtin School of Medical Research will be officially opened on the 6th of February 2017. The TDDP includes state-of-the-art robotic and liquid handling systems that will allow researchers to perform high throughput screens to identify novel treatments for cancer and other diseases. This facility is the first of its kind in the ACT, bringing ANU in line with other world-class research institutes around Australia.

Updated:  21 November 2017/Responsible Officer:  Director, ACRF/Page Contact:  Web Admin, ACRF